Filing Details

Accession Number:
0001104659-25-012308
Form Type:
13G Filing
Publication Date:
2025-02-11 19:00:00
Filed By:
IAF, LLC
Company:
Eterna Therapeutics Inc. (NYSEMKT:ERNA)
Filing Date:
2025-02-12
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
IAF, LLC 0 2,679,214 5.22%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Percentage of ownership in Row 11 is based on an aggregate of 51,374,713 shares of Common Stock outstanding as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 12, 2024.


SCHEDULE 13G


 
IAF, LLC
 
Signature:/s/ Edward Bennett
Name/Title:Edward G. R. Bennett, Authorized Person
Date:02/12/2025